Insider Trading History of Zen Wei Peu

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Zen Wei Peu since 2018. The trader's CIK number is 1746204. At the time of the last reporting, Zen Wei Peu was the Director of Emmaus Life Sciences, Inc.. (stock ticker symbol EMMA). Also see all insider trading activities at Emmaus Life Sciences, Inc..

Note that in the past ZEN Wei Peu also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Emmaus Life Sciences, Inc. (EMMA) by Zen Wei Peu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 EMMA 111,182 $446,175 0 $0 0 $0

Yearly summary of insider trading at Emmaus Life Sciences, Inc. (NONE) by Zen Wei Peu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 NONE 454,545 $2,999,997 0 $0 0 $0
2018 NONE 100,000 $1,000,000 0 $0 0 $0


Insider trading activities at 2 companies by Zen Wei Peu:

1. Emmaus Life Sciences, Inc. (EMMA)

2. Emmaus Life Sciences, Inc. (NONE)

Table 1. Insider trading of Emmaus Life Sciences, Inc. (EMMA) by Zen Wei Peu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-09-09 EMMA Buy 40,000 4.25 170,000
2019-09-06 EMMA Buy 12,545 4.20 52,689
2019-09-05 EMMA Buy 40,000 3.95 158,000
2019-09-04 EMMA Buy 12,892 3.70 47,700
2019-08-30 EMMA Buy 3,400 3.30 11,220
2019-08-28 EMMA Buy 2,345 2.80 6,566

Table 2. Insider trading of Emmaus Life Sciences, Inc. (NONE) by Zen Wei Peu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-07-09 NONE Buy 454,545 6.60 2,999,997
2018-12-18 NONE Buy 100,000 10.00 1,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zen Wei Peu (Director of Emmaus Life Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.